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The western barred bandicoot (Perameles bougainville) is an endangered Australian marsupial species 
in which a papillomatosis and carcinomatosis syndrome occurs. Bandicoot papillomatosis 
carcinomatosis virus type 1 (BPCV1) is associated with the lesions of this progressively debilitating 
syndrome. Five digoxigenin labeled DNA probes were generated for in situ hybridization (ISH), the 
technique was optimized and performed on formalin fixed paraffin embedded (FFPE) biopsies. 
Staining of keratinocyte and sebocytes nuclei within lesions was achieved with all 5 probes. The 
sensitivity of ISH (76.9%) surpassed that of polymerase chain reaction (PCR) (30.8%) for FFPE 
samples. The sensitivity of ISH varied from 81% (papillomas) and 70% (carcinoma in situ) to 29% 
(squamous cell carcinomas). The test’s specificity was confirmed using an irrelevant probe, and 
papillomas from other species. These results strengthen the association between BPCV1 and the 
western barred bandicoot papillomatosis and carcinomatosis syndrome and give insight into the biology 
of the virus-host interaction.  
  The western barred bandicoot, Perameles bougainville Quoy and Gaimard, 1824 is an endangered 
Australian peramelid marsupial species (Friend and Burbidge, 2002; IUCN, 2007; Tyndale-Biscoe, 
2005). Though once widely distributed across arid regions of southern mainland Australia, its range has 
contracted dramatically, due to predation by introduced carnivores, competition with introduced 
herbivores and habitat alterations (Friend and Burbidge, 2002). Believed extinct on the Australian 
mainland, natural populations of P. bougainville survive only on Dorre Island and Bernier Island, 
Western Australia (Friend and Burbidge, 2002; Tyndale-Biscoe, 2005). Captive breeding colonies were 
established to bolster their dwindling numbers, but the discovery of a papillomatosis and 
carcinomatosis syndrome hindered these efforts (Woolford et al., in press a). 
 
A novel virus, tentatively named bandicoot papillomatosis carcinomatosis virus type 1 (BPCV1), was 
detected in association with the papillomatosis and carcinomatosis syndrome using polymerase chain 
reaction (PCR), multiply primed rolling circle amplification, transmission electron microscopy and 
immunohistochemistry (Woolford et al., in press a, b). Significantly, BPCV1 had a double-stranded 
circular DNA genome and was similar to members of the Papillomaviridae in genomic size (~7.3 kb) 
and structural protein nucleotide and amino acid sequences, but had genomic organization and putative 
transforming protein nucleotide and amino acid sequences most similar to members of the 
Polyomaviridae (Woolford et al., in press b). Four open reading frames (ORFs) were predicted after 
examination of the BPCV1 genome and named according to the proteins they were likely to encode: 2 
putative capsid protein ORFs, L1 and L2, and 2 putative transforming protein ORFs, large T antigen 
(LTag) and small t antigen (stag) (Woolford et al., in press b). 
 
Mere detection of BPCV1 DNA was considered insufficient evidence to implicate it in the etiology of 
the papillomatosis and carcinomatosis syndrome, because papillomavirus DNA can be detected in skin 
swabs taken from apparently healthy animals (Antonsson and Hansson, 2002). Indeed, several novel virus isolates attributed to Papillomaviridae have been recently detected in Australian animals using 
PCR of swabs taken from non-lesional skin of koalas (Phascolarctos cinereus), eastern grey kangaroos 
(Macropus giganteus) and an echidna (Tachyglossus aculeatus) (Antonsson and McMillan, 2006). 
Furthermore, BPCV1 appears to resist degradation as it can be detected in the environment and on 
fomites using PCR (F. Armin-Grimm, pers. comm.). Therefore, we attempted to demonstrate BPCV1 
DNA in situ within lesional biopsies to provide compelling evidence linking BPCV1 with the 
papillomatosis and carcinomatosis syndrome.  
 
Biopsies were collected between 2000 and 2006 from P. bougainville expressing lesions typical of the 
papillomatosis and carcinomatosis syndrome. Samples were fixed in 10% neutral buffered formalin 
(>24 hours), processed with a Leica EG 1150C automated processor (Leica Microsystems) and 
embedded in paraffin. Sections were cut (5 µm thickness) using a Leica 2135 microtome (Leica 
Microsystems) and baked onto silanised glass microscope slides (ProSciTech). Haematoxylin and eosin 
stained slides of lesions were examined by light microscopy and categorized as either papillomas, 
carcinomas in situ or squamous cell carcinomas according to the classification system of Goldschmidt 
et al. (1998).  
 
Total genomic DNA was isolated from 25 mg of 13 formalin fixed paraffin embedded (FFPE) lesional 
tissues using the DNeasy Tissue Kit (Qiagen), according to the manufacturer’s protocol. PCR testing 
for the detection of BPCV1 DNA in total DNA extracted from FFPE lesional tissue was performed 
using a primer pair designed to amplify part of the putative BPCV1 L1 ORF region (5’-
GAGGAGGGACATCAGGTGAC-3’ and 5’-ATTGTTTTGCCCAGTTGCTC-3’). PCR was 
performed in a total volume of 25 µl, containing 0.3 µM of each primer, 200 µM of each 
deoxyribonucleic acid triphosphate (dNTP), 3.75 U.mL
-1 Taq DNA polymerase, 1.5 mM MgCl2 pH 8.5 
and 1x DNA polymerase reaction buffer (Fisher Biotech Australia), with 2 µl of the 1:10 diluted extracted lesional DNA as template. An automated thermocycler (Perkin Elmer Gene Amp PCR 
System 2400) set for block temperatures was programmed as follows: 5 minutes at 94 °C, then 25 
cycles of 30 seconds at 94 °C, 30 seconds at 55 °C and 30 seconds at 72 °C, then 7 minutes at 72 °C. 
The PCR product was electrophoresed through an ethidium bromide laced 2% agarose gel and 
examined for the expected 172 bp amplicon using UV transillumination.  
 
PCR primers were designed to amplify DNA segments within four BPCV1 ORFs: L1 (5’-
AGATTGGCGTTCCTAAGGTG-3’ and 5’-TCATCATCCCCTTCTTTTGC-3’; 250 bp), L2 (5’-
AAGGACAAAATTGAAGGAACCA-3’ and 5’-ACAGCATCAACTGGGAGGAT-3’; 236 bp), stag 
(5’-ATTCTGGATCCAGTGAGGGAA-3’ and 5’-CCCATAATTAACAGAATTCATCAGTGA-3’; 
308 bp) and LTag (5’-TGCAAAGTCCGCTAAGGATT-3’ and 5’-TGTGGCGAATCATCTTTGTC-
3’; 184 bp). PCR reactions were performed in a total volume of 40 µL with the following final 
concentrations of reagents: 200 µM each dNTP, 1x PCR reaction buffer, 1.5 mM MgCl2 pH 8.5, 200 
nM of each primer and 3.75 U.mL
-1 Taq DNA polymerase with 2 µL of 1:100 dilution of BPCV1 
positive control DNA as template. This mixture was subjected to 95 °C for 3 minutes, then 25 cycles of 
30 seconds at 95 °C, 30 seconds at 58 °C and 45 seconds at 72 °C, then 7 minutes at 72 °C in an 
automated thermocycler (Perkin Elmer Gene Amp PCR System 2400). The reaction was checked by 
visualizing an amplicon of expected size following electrophoresis through a 1% agarose gel laced with 
ethidium bromide, using a UV transilluminator. PCR products were purified using the QIAquick® 
PCR purification kit (Qiagen) according to the manufacturer’s guidelines and DNA concentration 
determined using a NanoDrop ND-1000 spectrophotometer (NanoDrop Technologies Inc.). 
 
Genomic DNA (1 µg) of plasmid DNA containing the BPCV1 genome cloned into pUC18 was 
incubated with 4 µL nick translation digoxigenin-labeling kit mixture (Roche Diagnostics) in a total volume of 20 µL at 14 °C for 4 hours. An extra 1 µL of the nick translation digoxigenin-labeling kit 
mixture was added to the reaction tube and incubation at 14 °C was continued for a further 20 hours. A 
1 µL aliquot of the reaction mixture was electrophoresed through an ethidium bromide laced 1% 
agarose gel and visualized under UV light to check that the genomic DNA had been digested to 
fragments shorter than ~500 bp. The reaction was stopped with 1 µL of 0.5 M EDTA pH 8 and the 
mixture was heated to 95 °C for 3 minutes, then labeled DNA species were purified using the 
QIAquick® PCR purification kit (Qiagen) to remove labeled fragments shorter than ~40 bp.  
Purified sub-ORF PCR product DNA (1 µg) was incubated with 4 µL nick translation digoxigenin-
labeling kit mixture (Roche Diagnostics) in a total volume of 20 µL at 14 °C for 2 hours. 1.25 µL of 0.5 
M EDTA pH 8 was added to stop the reaction and the mixture was heated to 95 °C for 3 minutes and 
stored at 4 °C. 
 
Biopsies on silanised slides were deparaffinized in two changes of xylene, then rehydrated through 
100%, 95%, 70% ethanol and tap water, then immersed in phosphate buffered saline with 0.05% 
Tween-20 pH 7.5 (PBST). Up to 50 µL DNA probe cocktail mixture (consisting of 50% formamide, 
10% dextran sulphate, 2x SSC buffer, >7.5 ng digoxigenin-labeled DNA) was pipetted onto each tissue 
section, covered with a glass coverslip and incubated in an oven at 95 °C for 15 minutes. Each slide 
was allowed to cool for at least 30 minutes. The cover slip was removed and the slide washed in 2x 
SSC buffer with 0.05% Tween-20 pH 7. Blocking solution (4 μg.mL
-1 bovine serum albumin in tris 
buffered saline with 0.05% Tween-20 pH 7 (TBST)) was added to the section for 5 minutes, then 
alkaline phosphatase conjugated anti-digoxigenin monoclonal antibody (Roche Diagnostics) diluted 
1:600 in the blocking solution was applied to completely cover the tissue and left at room temperature 
for 1 hour. Slides were thoroughly washed with TBST and antibody binding was demonstrated by 
covering the section with precipitating BM Purple AP substrate (Roche Diagnostics) laced with levamisole (300 µg.mL
-1) to block endogenous alkaline phosphatase activity. The slides were left to 
develop in a dark humid chamber for 4-16 hours, washed thoroughly in tap water, counterstained with 
Brazilin haematoxylin, washed again in tap water and wet-mounted with Apathy’s solution.  
 
A DNA probe created to detect DNA from an oyster parasite (Haplosporidium sp.) was kindly 
provided by Douglas Bearham as an irrelevant control probe, and tested on a section of positive control 
tissue. FFPE tissue sections from dog and southern brown bandicoot (Isoodon obesulus) papillomas 
were tested using BPCV1 DNA probes. Also, immediately following the rehydration of tissue sections, 
some slides were treated with DNase-free RNase (Sigma) for 30 minutes at room temperature to 
remove RNA from tissue sections. 
 
There was no staining of positive control tissue using the irrelevant Haplosporidium sp. DNA probe, 
nor were tissues from canine or southern brown bandicoot papillomas stained by our ISH technique. In 
positive control tissue sections tested with our ISH probes, the positive staining was restricted to the 
nuclei of keratinocytes and sebocytes. There was no staining of the cytoplasm or any part of the dermis, 
sweat glands or hypodermis and RNase pretreatment had no demonstrable effect on staining intensity 
or staining pattern. 
 
Of 13 lesions histologically consistent with the papillomatosis and carcinomatosis syndrome tested for 
BPCV1 DNA using ISH and PCR, 5 results were in agreement: 3 (23.1%) were positive by both 
methods and 2 (15.4%) were negative by both methods. Conflicting results were obtained in 8 cases: 7 
(53.8%) were ISH-positive but PCR negative, while only 1 (7.7%) was PCR-positive and ISH-
negative. Therefore, when performed on FFPE biopsies of lesions histologically consistent with the 
papillomatosis and carcinomatosis syndrome and assuming that all such lesions were BPCV1-
associated, the sensitivity of ISH was 76.9% and the sensitivity of PCR was 30.8%. Thirteen of 16 (81%) lesions histologically categorized as papillomas were positive using ISH, compared to 7 of 10 
(70%) carcinoma in situ and just 5 of 17 (29%) for squamous cell carcinomas. 
 
Many protocols for ISH recorded in the literature are remarkably complex and call for unusual reagents 
(Jones, 2002; Rolighed and Lindeberg, 1996). Our ISH protocol utilized a simplified and rapid protocol 
to yield excellent, reproducible results. Steps such as digestion in pepsin-HCl or proteinase K, post-
fixation, pre-hybridization and lengthy incubations following the DNA denaturation step were all 
entirely dispensable. We found immersing sections in alkaline phosphatase substrate buffer (pH 9 - 9.5) 
significantly inhibited the staining reaction. Trace amounts of levamisole added to BM Purple solution 
were highly effective at suppressing endogenous alkaline phosphatase activity (such as that seen in P. 
bougainville sweat glands), however at concentrations above approximately 1.5 mg.mL
-1 levamisole 
significantly slowed the colour development reaction. 
 
Given the novelty of the BPCV1 genome, it was important to verify that both papillomavirus-like and 
polyomavirus-like DNA sequences were detectable in situ within the lesions of the western barred 
bandicoot papillomatosis and carcinomatosis syndrome. The identical staining patterns of keratinocytes 
and sebocytes obtained using DNA probes constructed to anneal with L1, L2, LTag and stag ORFs as 
well as the BPCV1 genomic probe confirmed the presence of the novel virus genotype, including both 
papillomavirus and polyomavirus-like ORFs within lesions. Furthermore, the viral DNA sequences 
were found most prominently in the nuclei of basal keratinocytes of the epidermis and external root 
sheath, followed by keratinocytes of the stratum spinosum and to a lesser extent, stratum granulosum. 
This pattern of distribution is largely consistent with the expected biology of papillomavirus infections 
(Howley and Lowy, 2007; Nicholls et al., 2001; Peh et al., 2002). Interestingly, nuclei of sebaceous 
cells also stained positively using this ISH technique.  Detection of virus DNA in sebocytes is unusual 
but not unprecedented: human papillomavirus DNA has been demonstrated by ISH in sebaceous carcinomas (Hayashi et al., 1994) and Micromys minutus papillomavirus has been associated with 
sebaceous carcinoma in that species (Sundberg et al., 1988). It is conceivable that P. bougainville 
sebocytes could be permissive for BPCV1 growth. If that is the case, BPCV1 virions may be shed in 
sebum as well as exfoliated epithelial cells. Despite sebaceous cells and hair follicle keratinocytes 
staining positively, sweat gland nuclei showed no positive staining, indicating that the sweat gland cells 
may be refractory to infection with BPCV1. One severely affected P. bougainville had multifocal 
pulmonary metastases of a squamous cell carcinoma. While the hyperplastic cutaneous lesions from 
this individual were strongly ISH-positive, the pulmonary metastases were only very weakly ISH-
positive. It remains unclear whether this is related to a genuine ‘hit and run’ transforming effect of the 
virus. If it is possible for BPCV1 DNA to integrate into the host’s DNA, perhaps such integrated 
components are less easily detected with this ISH technique. 
 
Southern brown bandicoot papillomatosis is also associated with viral DNA and the BPCV1 stag DNA 
probe has a nucleotide sequence similarity of ~91% to the corresponding region of the southern brown 
bandicoot virus isolates genome (Bennett et al., in preparation). The lack of cross reactivity of this 
probe with lesions from a related species, the southern brown bandicoot (Isoodon obesulus), indicated a 
high level of specificity for the DNA probes employed in this ISH method. 
 
These ISH results confirmed that BPCV1 DNA was present within the cutaneous and muco-cutaneous 
lesions of western barred bandicoot papillomatosis and carcinomatosis syndrome and suggested that 
ISH was a more sensitive test than PCR for FFPE tissue samples at detecting BPCV1 in papillomatous 
lesions from P. bougainville. ISH demonstrated BPCV1 DNA in 7 of 9 (77.8%) cases that tested 
negative using PCR. The single case for which ISH failed to detect BPCV1 DNA but PCR succeeded 
was a squamous cell carcinoma. The sensitivity of this ISH technique diminished as lesions progressed from benign to malignant histological grades. This optimized ISH technique can reliably diagnose 
BPCV1 infection in properly collected and processed pre-neoplastic biopsies from P. bougainville. 
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Figures Captions 
Figure 1. In situ hybridization performed on papillomas from P. bougainville, demonstrating strong 
positive staining restricted to the nuclei of external root sheath keratinocytes. The dermis and sweat 
glands are unstained. Brazilin haematoxylin counter-stain; bar = 50 μm. (A) Genomic probe. (B) L1 
probe. (C) L2 probe. (D) LTag probe. (E) stag probe. 
 
Figure 2. In situ hybridization performed on papillomas from P. bougainville, demonstrating positive 
staining of sebocyte nuclei. Brazilin haematoxylin counter-stain; bar = 20 μm. (A) Genomic probe. (B) 
L1 probe. (C) L2 probe. (D) LTag probe. (E) stag probe.  
Figure 3. Selected controls used to confirm the specificity of the in situ hybridization technique. 
Brazilin haematoxylin counter-stain; bar = 50 μm. (A) DNase-free RNase pretreatment did not affect 
positive nuclear staining. (B) A digoxigenin-labeled DNA probe designed to demonstrate 
Haplosporidium sp. DNA sequences failed to stain papillomas from P. bougainville. (C) Papillomas 
from a related bandicoot species, Isoodon obesulus, did not stain positively using any digoxigenin-
labeled DNA probes designed to detect BPCV1. 
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